Algok Bio

Algok Bio Inc. is a biopharmaceutical start-up on a mission to become a global leader in women’s health by developing targeted therapies for gynecological cancers, particularly against folate receptor alpha. Our vision extends to broadening our drug pipeline to address other major cancers, positioning us at the forefront of transformative oncology innovations. Driven by a team of experienced drug development professionals, we are passionate about discovering and advancing promising therapeutic programs and precision medicine approaches. Our focus lies in bridging the gap between drug discovery and commercialization by concentrating on candidates ready to enter preclinical studies and clinical-stage assets—a critical yet challenging transition in the pharmaceutical industry. With proven expertise in identifying successful leads, we in-license or acquire the most promising candidates for development and commercialization. Our name, inspired by the Korean word "Algok" (meaning "grain"), reflects our approach to separating the most valuable drug candidates from the rest, much like a farmer selecting nourishing wheat over inedible chaff. Visit our website at Algokbio.com to learn more about our relentless commitment to advancing innovative therapies and precision medicine solutions that transform healthcare and improve patients' lives. Connect with us to be part of the journey in redefining the future of oncology treatments.